BC
Blackhill Capital Portfolio holdings
AUM
$1.73B
1-Year Return
14.57%
This Quarter Return
+3.91%
1 Year Return
+14.57%
3 Year Return
+150.13%
5 Year Return
+277.07%
10 Year Return
+454.51%
AUM
$896M
AUM Growth
+$33.1M
(+3.8%)
Cap. Flow
+$4.94M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
86.92%
Holding
52
New
–
Increased
4
Reduced
7
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$6.36M |
| 2 |
Merck
MRK
|
+$904K |
| 3 |
AbbVie
ABBV
|
+$590K |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$43.4K |
Top Sells
| 1 |
Zoetis
ZTS
|
+$1.66M |
| 2 |
Eli Lilly
LLY
|
+$515K |
| 3 |
Williams-Sonoma
WSM
|
+$471K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$250K |
| 5 |
Zimmer Biomet
ZBH
|
+$25.8K |
Sector Composition
| 1 | Consumer Discretionary | 53.95% |
| 2 | Healthcare | 29.96% |
| 3 | Technology | 7.19% |
| 4 | Communication Services | 2.16% |
| 5 | Consumer Staples | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Norfolk Southern
NSC
$61.6B
| $42.4K | ﹤0.01% |
200
| – | – |
|
52
Consolidated Edison
ED
$35.2B
| $24.2K | ﹤0.01% |
253
| – | – |
|